Literature DB >> 25102093

Clinical and molecular studies in four patients with SRY-positive 46,XX testicular disorders of sex development: implications for variable sex development and genomic rearrangements.

Shinichi Nakashima1, Akira Ohishi1, Fumio Takada2, Hideki Kawamura3, Maki Igarashi4, Maki Fukami4, Tsutomu Ogata1.   

Abstract

We report four patients with SRY-positive 46,XX testicular disorders of sex development (46,XX-TDSD) (cases 1-4). Case 1 exhibited underdeveloped external genitalia with hypospadias, case 2 manifested micropenis and cases 3 and 4 showed normal external genitalia. The Xp;Yp translocations occurred between the X- and the Y-differential regions in case 1, between PRKX and inverted PRKY in case 2 and between the X-chromosomal short arm pseudoautosomal region and the Y-differential regions in cases 3 and 4. The distance of the Yp breakpoint from SRY was ~0.75 Mb in case 1, ~6.5 Mb in case 2, ~2.3 Mb in case 3 and ~72 kb in case 4. The Xp;Yp translocation occurred within an 87-bp homologous segment of PRKX and PRKY in case 2, and between non-homologous regions with addition of an 18-bp sequence of unknown origin in case 4. X-inactivation analysis revealed random inactivation in cases 1-4. The results argue against the notion that undermasculinization in 46,XX-TDSD is prone to occur when translocated Yp materials are small (<100 kb of the Y-differential region), and imply that the Xp;Yp translocations result from several mechanisms including non-allelic homologous recombination and non-homologous end joining.

Entities:  

Mesh:

Year:  2014        PMID: 25102093     DOI: 10.1038/jhg.2014.70

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  19 in total

1.  Incomplete masculinisation of XX subjects carrying the SRY gene on an inactive X chromosome.

Authors:  K Kusz; M Kotecki; A Wojda; M Szarras-Czapnik; A Latos-Bielenska; A Warenik-Szymankiewicz; A Ruszczynska-Wolska; J Jaruzelska
Journal:  J Med Genet       Date:  1999-06       Impact factor: 6.318

2.  Female carriers of Xp22.3 deletion including MRX locus.

Authors:  K Muroya; T Kosho; T Ogata; M Matsuo
Journal:  Am J Med Genet       Date:  1999-06-04

3.  What have studies of genomic disorders taught us about our genome?

Authors:  Alexandra D Simmons; Claudia M B Carvalho; James R Lupski
Journal:  Methods Mol Biol       Date:  2012

4.  A sex chromosome rearrangement in a human XX male caused by Alu-Alu recombination.

Authors:  F Rouyer; M C Simmler; D C Page; J Weissenbach
Journal:  Cell       Date:  1987-11-06       Impact factor: 41.582

5.  Sex-determining gene(s) on distal 9p: clinical and molecular studies in six cases.

Authors:  K Muroya; T Okuyama; K Goishi; Y Ogiso; S Fukuda; J Kameyama; H Sato; Y Suzuki; H Terasaki; H Gomyo; K Wakui; Y Fukushima; T Ogata
Journal:  J Clin Endocrinol Metab       Date:  2000-09       Impact factor: 5.958

6.  Genetic evidence that ZFY is not the testis-determining factor.

Authors:  M S Palmer; A H Sinclair; P Berta; N A Ellis; P N Goodfellow; N E Abbas; M Fellous
Journal:  Nature       Date:  1989 Dec 21-28       Impact factor: 49.962

7.  X-inactivation profile reveals extensive variability in X-linked gene expression in females.

Authors:  Laura Carrel; Huntington F Willard
Journal:  Nature       Date:  2005-03-17       Impact factor: 49.962

Review 8.  Sex determination and its pathology in man.

Authors:  A J Schafer
Journal:  Adv Genet       Date:  1995       Impact factor: 1.944

9.  X-linked syndrome of branchial arch and other defects.

Authors:  H V Toriello; J V Higgins; J Abrahamson; D F Waterman; W D Moore
Journal:  Am J Med Genet       Date:  1985-05

Review 10.  Position effect in human genetic disease.

Authors:  D J Kleinjan; V van Heyningen
Journal:  Hum Mol Genet       Date:  1998       Impact factor: 6.150

View more
  1 in total

1.  The first case of 38,XX (SRY-positive) disorder of sex development in a cat.

Authors:  Izabela Szczerbal; Monika Stachowiak; Stanislaw Dzimira; Krystyna Sliwa; Marek Switonski
Journal:  Mol Cytogenet       Date:  2015-03-26       Impact factor: 2.009

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.